These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 36598859)
41. Poor response to sintilimab plus chemotherapy in a pulmonary epithelioid hemangioendothelioma patient: a case report. Zeng H; Tang X; Tian X; Liu Y; Tian P Immunotherapy; 2023 Feb; 15(2):77-83. PubMed ID: 36695105 [TBL] [Abstract][Full Text] [Related]
43. [Epithelioid hemangioendothelioma]. Cousin S; Le Loarer F; Crombé A; Karanian M; Minard-Colin V; Penel N Bull Cancer; 2019 Jan; 106(1):73-83. PubMed ID: 30527817 [TBL] [Abstract][Full Text] [Related]
44. Epithelioid hemangioendotheliomas of the liver and lung in children and adolescents. Hettmer S; Andrieux G; Hochrein J; Kurz P; Rössler J; Lassmann S; Werner M; von Bubnoff N; Peters C; Koscielniak E; Sparber-Sauer M; Niemeyer C; Mentzel T; Busch H; Boerries M Pediatr Blood Cancer; 2017 Dec; 64(12):. PubMed ID: 28598585 [TBL] [Abstract][Full Text] [Related]
45. Epithelioid haemangioendothelioma of the uterine cervix with CAMTA1/WWTR1 translocation. Matsika A; Anderson JK; Bligh JF; Whitehouse AL Pathology; 2014 Jun; 46(4):355-8. PubMed ID: 24798168 [No Abstract] [Full Text] [Related]
46. TFE3-rearranged hepatic epithelioid hemangioendothelioma-a case report with immunohistochemical and molecular study. Kuo FY; Huang HY; Chen CL; Eng HL; Huang CC APMIS; 2017 Sep; 125(9):849-853. PubMed ID: 28585251 [TBL] [Abstract][Full Text] [Related]
47. [Epithelioid hemangioendothelioma with TFE3 translocation in soft tissue:a clinicopathological study]. Song QY; Zhu XM; Song GX; Li X; Fan QH; Zhang ZH; Gong QX Zhonghua Bing Li Xue Za Zhi; 2021 Oct; 50(10):1151-1156. PubMed ID: 34619869 [No Abstract] [Full Text] [Related]
48. Epithelioid hemangioendotheliomas with TFE3 gene translocations are compossible with CAMTA1 gene rearrangements. Lee SJ; Yang WI; Chung WS; Kim SK Oncotarget; 2016 Feb; 7(7):7480-8. PubMed ID: 26840265 [TBL] [Abstract][Full Text] [Related]
49. CAMTA1 is a useful immunohistochemical marker for diagnosing epithelioid haemangioendothelioma. Shibuya R; Matsuyama A; Shiba E; Harada H; Yabuki K; Hisaoka M Histopathology; 2015 Dec; 67(6):827-35. PubMed ID: 25879300 [TBL] [Abstract][Full Text] [Related]
50. Diagnostic utility of FOSB immunohistochemistry in pseudomyogenic hemangioendothelioma and its histological mimics. Sugita S; Hirano H; Kikuchi N; Kubo T; Asanuma H; Aoyama T; Emori M; Hasegawa T Diagn Pathol; 2016 Aug; 11(1):75. PubMed ID: 27515856 [TBL] [Abstract][Full Text] [Related]
51. A Matched Molecular and Clinical Analysis of the Epithelioid Haemangioendothelioma Cohort in the Stafford Fox Rare Cancer Program and Contextual Literature Review. Abdelmogod A; Papadopoulos L; Riordan S; Wong M; Weltman M; Lim R; McEvoy C; Fellowes A; Fox S; Bedő J; Penington J; Pham K; Hofmann O; Vissers JHA; Grimmond S; Ratnayake G; Christie M; Mitchell C; Murray WK; McClymont K; Luk P; Papenfuss AT; Kee D; Scott CL; Goldstein D; Barker HE Cancers (Basel); 2023 Sep; 15(17):. PubMed ID: 37686662 [TBL] [Abstract][Full Text] [Related]
52. TFE3 rearranged epithelioid hemangioendothelioma of bone: A clinicopathological, immunohistochemical and molecular study of two cases. Zhang HZ; Dong L; Wang SY; Yang XQ Ann Diagn Pathol; 2020 Jun; 46():151487. PubMed ID: 32151991 [TBL] [Abstract][Full Text] [Related]
53. Clinicopathologic Characterization of Epithelioid Hemangioendothelioma in a Series of 62 Cases: A Proposal of Risk Stratification and Identification of a Synaptophysin-positive Aggressive Subset. Shibayama T; Makise N; Motoi T; Mori T; Hiraoka N; Yonemori K; Watanabe SI; Esaki M; Morizane C; Okuma T; Kawai A; Ushiku T; Yatabe Y; Yoshida A Am J Surg Pathol; 2021 May; 45(5):616-626. PubMed ID: 33729740 [TBL] [Abstract][Full Text] [Related]
55. Endothelial cell malignancies in infants, children and adolescents: Treatment results of three Cooperative Weichteilsarkom Studiengruppe (CWS) trials and one registry. Sparber-Sauer M; Koscielniak E; Vokuhl C; Schmid I; Bien E; Seitz G; Hallmen E; von Kalle T; Scheer M; Münter M; Bielack SS; Niggli F; Ljungman G; Fuchs J; Hettmer S; Rössler J; Klingebiel T; Pediatr Blood Cancer; 2020 Mar; 67(3):e28095. PubMed ID: 31814291 [TBL] [Abstract][Full Text] [Related]
56. CAMTA1 immunostaining is not useful in differentiating epithelioid hemangioendothelioma from its potential mimickers. Yusıflı Z; Kösemehmetoğlu K Turk Patoloji Derg; 2014; 30(3):159-65. PubMed ID: 25110239 [TBL] [Abstract][Full Text] [Related]
57. Fusion of the Genes Panagopoulos I; Lobmaier I; Gorunova L; Heim S Cancer Genomics Proteomics; 2019; 16(4):293-298. PubMed ID: 31243110 [TBL] [Abstract][Full Text] [Related]
58. Current Model Systems for Investigating Epithelioid Haemangioendothelioma. Neil E; Kouskoff V Cancers (Basel); 2023 May; 15(11):. PubMed ID: 37296967 [TBL] [Abstract][Full Text] [Related]
59. Cytologic features of hepatic YAP1-TFE3 rearranged epithelioid hemangioendothelioma. Bourgeau M; Martinez A; Deeb KK; Reid MD; Lewis M; Point du Jour KS; Lai J; Shi Q Diagn Cytopathol; 2021 Dec; 49(12):E447-E452. PubMed ID: 34411462 [TBL] [Abstract][Full Text] [Related]